Founded
31 Dec 1998
Website
VCID: 127463
Profile
Corporate information
Official name
Illumina Incorporated
Registration country
Investment activity status
Active investor
Company type
Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.Funding
Funding rounds
(31 Dec 1998)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Venrock Associates | The venture capital arm of the Rockefeller Family. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | United States | |
|
BayStar Capital | |||
|
Celera Corp | A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases | United States | |
|
Chevron Technology Ventures LLC | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron | United States | |
|
Comdisco Inc | United States | ||
|
|
CW Group Inc | United States | ||
|
Dow Venture Capital | The corporate venture capital unit of Dow Chemical Co | United States | |
|
JPMorgan Chase & Co | United States | ||
|
Oxford Bioscience Partners III LP | United States | ||
|
|
Roche Holding Ltd |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup |
+1 (415) 565-7103 |
N/A |
|
|
BayStar Capital |
N/A | |
|
|
Celera Corp A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases |
N/A | |
|
|
Chevron Technology Ventures LLC Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
+1 (713) 954-6974 |
N/A |
|
|
Comdisco Inc |
N/A | |
|
|
CW Group Inc |
+1 (202) 508-1040 |
N/A |
|
|
Dow Venture Capital The corporate venture capital unit of Dow Chemical Co |
+1 (989) 636-5692 |
N/A |
|
|
JPMorgan Chase & Co |
N/A | |
|
|
Oxford Bioscience Partners III LP |
N/A | |
|
|
Roche Holding Ltd |
N/A | |
|
|
Venrock Associates The venture capital arm of the Rockefeller Family. |
+1 (617) 995-2000 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
|
Illumina Ventures I |
31 Dec 2018 | Fund Closing Active |
||
|
Oxford Nanopore Technologies Ltd Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. |
United Kingdom | 26 Apr 2011 | Venture Exited |
|
|
|
Helixis Inc Medical equipment company that develops low-cost molecular diagnostic products. |
United States | 30 Apr 2010 | Acquisition USD 105,000,000 (USD 105,000,000) deal size. Active |
|
|
|
Nextbio |
United States | Acquisition Led the investment round. Active |
||
|
|
Avantome |
Acquisition Initial investment. Led the investment round. Active |